Fol. Biol. 2003, 49, 235-237
https://doi.org/10.14712/fb2003049060235
No Association between Oxidative Stress and IL-6 in NIDDM Patients with Nephropathy
References
1. 1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
< , J. W. (https://doi.org/10.2337/diab.40.4.405>
2. 1978) Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310.
< , J. A., Aust, S. D. (https://doi.org/10.1016/S0076-6879(78)52032-6>
3. 2001) Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44, 1957-1972.
< , M. E. (https://doi.org/10.1007/s001250100000>
4. 1991) Interleukin-6 in insulin dependent diabetes mellitus. Diabetes 40, (suppl. 1), 264A.
, B., Messent, J. et al. (
5. 1992) Role of cytokines in inducing hyperlipidemia. Diabetes 41, (suppl. 2), 97-101.
< , K. F., Grunfeld, C. (https://doi.org/10.2337/diab.41.2.S97>
6. 1991) Distribution of interleukin-6 in normal and diseased human kidney. Lab. Invest. 65, 61-66.
, A., Matsuo, S. et al. (
7. 1999) Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res. Clin. Pr. 45, 147-151.
< , H., Kim, K. H. (https://doi.org/10.1016/S0168-8227(99)00044-3>
8. 1990) Biological and clinical aspects of interleukin 6. Immunol. Today 11, 443-449.
< , T., Akira, S., Taga, T., Kishimoto, T. (https://doi.org/10.1016/0167-5699(90)90173-7>
9. 1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with noninsulin dependent diabetes with or without diabetic nephropathy. Nephrol. Dial. Transplant. 13, 2829-2832.
< , K. Z., Luciak, M., Blaszczyk, J., Pawlak, W. (https://doi.org/10.1093/ndt/13.11.2829>
10. 1999) Genetics of diabetic nephropathy. Kidney Int. 55, 1582-1596.
< , A. S. (https://doi.org/10.1046/j.1523-1755.1999.00371.x>
11. 2000) Molecular mechanism of diabetic nephropathy. Clin. Chim. Acta 297, 135-144.
< , R., Schleicher, E. D. (https://doi.org/10.1016/S0009-8981(00)00240-0>
12. 1991) Serum levels of tumor necrosis factor and IL-1α and IL-1β in diabetic patients. Diabetes Care 14, 63-65.
< , A. D., Reed, R. L., Meredith, K. E., Scuderi, P. (https://doi.org/10.2337/diacare.14.1.63>
13. 1994) Detection of serum IL-6 in patients with diabetic nephropathy. Nephron 68, 284-285.
< , K., Tomina, Y., Sei, C., Kurusu, A., Tashiro, K., Yamaguchi, Y., Kodera, S., Hishiki, T., Shirato, I., Koide, H. (https://doi.org/10.1159/000188281>
14. 2000) Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85, 81-85.
< , M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., Kawashima, S. (https://doi.org/10.1159/000045634>